21 August 2018 - NHS trusts are warning that the health service is not prepared for a no-deal Brexit and that drug supplies could be affected as a result.
In a private letter sent to Simon Stevens, head of NHS England, and Ian Dalton, chief executive of NHS Improvement, leaked to The Times, NHS Providers chief executive Chris Hopson said that in the event of a no-deal or hard Brexit “the entire supply chain of pharmaceuticals could be adversely affected” from the start.
Furthermore, “public health and disease control co-ordination could also suffer and our efforts to reassure, retain and attract the European workforce on which the NHS relies could also be jeopardised,” he warned, according to the paper.